These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17457489)

  • 1. Evaluation of drug and poison information center in Saudi Arabia during the period 2000-2002.
    Asiri YA; Al-Arifi MN; Al-Sultan MS; Gubara OA
    Saudi Med J; 2007 Apr; 28(4):617-9. PubMed ID: 17457489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and evaluation of pharmacists' commonly used drug information sources.
    Wong PS; Ko Y; Sklar GE
    Ann Pharmacother; 2009 Feb; 43(2):347-52. PubMed ID: 19193588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of consumer users of a statewide drug information service.
    Smith GH; Einarson TR
    Am J Hosp Pharm; 1985 Jul; 42(7):1557-61. PubMed ID: 4025353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for drug and poison information--the Singapore physicians' perspective.
    Ponampalam R; Anantharaman V
    Singapore Med J; 2003 May; 44(5):231-42. PubMed ID: 13677359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information-seeking behaviors and attitudes of physicians toward drug information centers in Saudi Arabia.
    Abou-Auda HS
    Saudi Med J; 2008 Jan; 29(1):107-15. PubMed ID: 18176684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of initial requests for information of non-exposure related topics at a regional poison center.
    Winter JP; Hornfeldt CS; Weiland MJ; Ling LJ
    Vet Hum Toxicol; 1988 Apr; 30(2):108-9. PubMed ID: 3381478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of medication identification requests managed by a U.S.-certified regional poison information center.
    Krenzelok EP; Mrvos R
    Clin Toxicol (Phila); 2009 Apr; 47(4):364-5. PubMed ID: 19365774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug information services in an oncology institution.
    Dana WJ; Ballentine R; Gamble C; Lynch J
    Am J Hosp Pharm; 1978 Apr; 35(4):434-6. PubMed ID: 645717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumer focus of a university drug and poison information center.
    Sigell LT; Piascik MF; Parker RE; Nelson ED; Williams RB
    Am J Hosp Pharm; 1980 Sep; 37(9):1206-10. PubMed ID: 7416175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifteen years of drug information in Christchurch Hospital.
    Gardiner S; Kirkpatrick C; Begg E
    N Z Med J; 2001 Sep; 114(1139):393-5. PubMed ID: 11665925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External quality assurance committee for drug information services.
    Smith CJ; Sylvia LM
    Am J Hosp Pharm; 1990 Apr; 47(4):787-91. PubMed ID: 2321653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and poison information resources on the Internet, Part 2: Identification and evaluation.
    Marra CA; Carleton BC; Lynd LD; Marra F; McDougal AR; Chow D; McKerrow R
    Pharmacotherapy; 1996; 16(5):806-18. PubMed ID: 8888076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician use and evaluation of a hospital-based drug information center.
    Hayman JN; Brown TR; Smith MC; Liao W
    Am J Hosp Pharm; 1978 Oct; 35(10):1238-40. PubMed ID: 696732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of information sources at a university hospital drug information service.
    Joy ME; Arana CJ; Gallo GR
    Am J Hosp Pharm; 1986 May; 43(5):1226-9. PubMed ID: 3717179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a hospital-based drug information center.
    Merritt GJ; Garnett WR; Eckel FM
    Am J Hosp Pharm; 1977 Jan; 34(1):42-6. PubMed ID: 831474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
    Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
    Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of a community pharmacy-operated national drug information call center in Finland.
    Pohjanoksa-Mäntylä MK; Antila J; Eerikäinen S; Enäkoski M; Hannuksela O; Pietilä K; Airaksinen M
    Res Social Adm Pharm; 2008 Jun; 4(2):144-52. PubMed ID: 18555967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A drug information service quality assurance audit.
    Hart LL; Miwa LJ; Millares M
    Hosp Formul; 1989 Jul; 24(7):383-6, 388-9. PubMed ID: 10293845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poison Control and the Drug Information Center: the Palestinian experience.
    Sawalha AF
    Isr Med Assoc J; 2008 Nov; 10(11):757-60. PubMed ID: 19070281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and disadvantages of combining poison control and drug information centers.
    Troutman WG; Wanke LA
    Am J Hosp Pharm; 1983 Jul; 40(7):1219-22. PubMed ID: 6881165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.